Limitation of the excessive extracellular matrix turnover is a major determinant of the beneficial effect of spironolactone on survival in patients with CHF: Insights from the RALES trial.
Saved in:
| Title: | Limitation of the excessive extracellular matrix turnover is a major determinant of the beneficial effect of spironolactone on survival in patients with CHF: Insights from the RALES trial. |
|---|---|
| Authors: | Zannad, F.1, Alla, F.1, Dousset, B.2, Pitt, B.3 |
| Source: | European Journal of Heart Failure. Jun2000, Vol. 2 Issue S1, p98-98. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 13889842 |
|---|---|
| DOI: | 10.1016/S1388-9842(00)80350-5 |
